ENVX Quote, Financials, Valuation and Earnings

Ideal Power has a net margin of -522.03% compared to Enovix's net margin of -485622.38%. Enovix's return on equity of -112.38% beat Ideal Power's return on equity of -59.68%.

Enovix has a consensus price target of $27.25, signalling upside risk potential of 170.34%. On the other hand Ideal Power has an analysts' consensus of -- which suggests that it could grow by 105.58%. Given that Enovix has higher upside potential than Ideal Power, analysts believe Enovix is more attractive than Ideal Power.

Enovix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ideal Power has a beta of 1.054, suggesting its more volatile than the S&P 500 by 5.376%.

Enovix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ideal Power offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enovix pays -- of its earnings as a dividend. Ideal Power pays out -- of its earnings as a dividend.

Enovix quarterly revenues are $4.3M, which are larger than Ideal Power quarterly revenues of $550. Enovix's net income of -$22.5M is lower than Ideal Power's net income of -$2.7M. Notably, Enovix's price-to-earnings ratio is -- while Ideal Power's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enovix is 82.75x versus 357.12x for Ideal Power. Usually stocks with elevated PS ratios are considered overvalued.

Microvast Holdings has a net margin of -522.03% compared to Enovix's net margin of 13.07%. Enovix's return on equity of -112.38% beat Microvast Holdings's return on equity of -21.49%.

Enovix has a consensus price target of $27.25, signalling upside risk potential of 170.34%. On the other hand Microvast Holdings has an analysts' consensus of -- which suggests that it could grow by 118.58%. Given that Enovix has higher upside potential than Microvast Holdings, analysts believe Enovix is more attractive than Microvast Holdings.

Enovix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Microvast Holdings has a beta of 2.544, suggesting its more volatile than the S&P 500 by 154.382%.

Enovix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Microvast Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enovix pays -- of its earnings as a dividend. Microvast Holdings pays out -- of its earnings as a dividend.

Enovix quarterly revenues are $4.3M, which are smaller than Microvast Holdings quarterly revenues of $101.4M. Enovix's net income of -$22.5M is lower than Microvast Holdings's net income of $13.2M. Notably, Enovix's price-to-earnings ratio is -- while Microvast Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enovix is 82.75x versus 1.62x for Microvast Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Plug Power has a net margin of -522.03% compared to Enovix's net margin of -121.55%. Enovix's return on equity of -112.38% beat Plug Power's return on equity of -45.97%.

Enovix has a consensus price target of $27.25, signalling upside risk potential of 170.34%. On the other hand Plug Power has an analysts' consensus of $4.01 which suggests that it could grow by 12.85%. Given that Enovix has higher upside potential than Plug Power, analysts believe Enovix is more attractive than Plug Power.

Enovix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Plug Power has a beta of 1.763, suggesting its more volatile than the S&P 500 by 76.272%.

Enovix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plug Power offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enovix pays -- of its earnings as a dividend. Plug Power pays out -- of its earnings as a dividend.

Enovix quarterly revenues are $4.3M, which are smaller than Plug Power quarterly revenues of $173.7M. Enovix's net income of -$22.5M is higher than Plug Power's net income of -$211.2M. Notably, Enovix's price-to-earnings ratio is -- while Plug Power's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enovix is 82.75x versus 2.60x for Plug Power. Usually stocks with elevated PS ratios are considered overvalued.

Ultralife has a net margin of -522.03% compared to Enovix's net margin of 0.72%. Enovix's return on equity of -112.38% beat Ultralife's return on equity of 6.98%.

Enovix has a consensus price target of $27.25, signalling upside risk potential of 170.34%. On the other hand Ultralife has an analysts' consensus of -- which suggests that it could grow by 92.57%. Given that Enovix has higher upside potential than Ultralife, analysts believe Enovix is more attractive than Ultralife.

Enovix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ultralife has a beta of 0.947, suggesting its less volatile than the S&P 500 by 5.274%.

Enovix has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ultralife offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Enovix pays -- of its earnings as a dividend. Ultralife pays out -- of its earnings as a dividend.

Enovix quarterly revenues are $4.3M, which are smaller than Ultralife quarterly revenues of $35.7M. Enovix's net income of -$22.5M is lower than Ultralife's net income of $258K. Notably, Enovix's price-to-earnings ratio is -- while Ultralife's PE ratio is 13.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Enovix is 82.75x versus 0.73x for Ultralife. Usually stocks with elevated PS ratios are considered overvalued.